Inflammasome Formation in Granulomas in Cardiac Sarcoidosis-Reference-Cited by-同舟云学术

Inflammasome Formation in Granulomas in Cardiac Sarcoidosis

Published:2019-09 Issue:9 Volume:12 Page:
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ: Arrhythmia and Electrophysiology

Author:

Kron Jordana¹,Mauro Adolfo Gabriele¹,Bonaventura Aldo¹²,Toldo Stefano¹,Salloum Fadi N.¹,Ellenbogen Kenneth A.¹,Abbate Antonio¹

Affiliation:

1. Pauley Heart Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond (J.K., A.G.M., A.B., S.T., F.N.S., K.A.E., A.A.).

2. First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Italy (A.B.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. The NLRP3 inflammasome in acute myocardial infarction

2. Significance of the Interleukin-1 Receptor Antagonist/Interleukin-1β Ratio as a Prognostic Factor in Patients with Pulmonary Sarcoidosis

3. Direct evidence for granuloma-inducing activity of interleukin-1. Induction of experimental pulmonary granuloma formation in mice by interleukin-1-coupled beads.;Kasahara K;Am J Pathol,1988

4. HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis

5. Interleukin-1 blockade in cardiovascular diseases: a clinical update

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental drugs for sarcoidosis;Journal of Autoimmunity;2024-03

2. Cardiac Involvement in Patients With Multisystem Inflammatory Syndrome in Adults;Journal of the American Heart Association;2024-02-20

3. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases;Nature Reviews Cardiology;2023-11-03

4. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1;European Journal of Clinical Investigation;2023-10-14

5. Interleukin-1 Inhibition for the Prevention and Treatment of Heart Failure;Journal of Cardiovascular Pharmacology;2023-10-10